Data / Drug companies / Magnesium sulfate heptahydrate
Magnesium sulfate heptahydrate: 20 companies and 45 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Magnesium sulfate heptahydrate is listed in the FDA National Drug Code Directory by 20 companies, with 45 products in commercial distribution. 22 of the products (48.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; liquid; spray, and the newest product started marketing on October 30, 2026.
The request: Get every company that lists magnesium sulfate heptahydrate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 20
- Products
- 45
- Generic (ANDA) products
- 22 (48.9%)
- Application numbers
- 11
- Routes
- Intravenous, Intramuscular, Topical, Oral
- Brand names
- Magnesium Sulfate, Magnesium Sulfate, Magnesium Sulfate in Water, Magnesium Sulfate, Theraworx Relief Muscle Cramp and Spasm Relief, Phuel, Theraworx Relief, Magnesium Sulfate in 5% Dextrose
- openFDA record search
- api.fda.gov
Companies that list magnesium sulfate heptahydrate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Fresenius Kabi USA, LLC | 9 | injection, solution | Generic drugs (ANDA) | March 15, 2016 |
| Avadim Holdings, Inc. | 6 | liquid; aerosol, foam | Unapproved homeopathic products | November 8, 2018 |
| B. Braun Medical Inc. | 4 | injection, solution | Generic drugs (ANDA) | April 26, 2021 |
| Baxter Healthcare Corporation | 4 | injection, solution | Generic drugs (ANDA) | January 8, 2026 |
| Medical Purchasing Solutions, LLC | 3 | injection, solution | New drug applications (NDA) | May 28, 2025 |
| Boiron | 2 | pellet | Unapproved homeopathic products | January 1, 2025 |
| Gland Pharma Limited | 2 | injection, solution | Generic drugs (ANDA) | July 10, 2020 |
| ProPharma Distribution | 2 | injection, solution | New drug applications (NDA) | August 8, 2000 |
| Walgreen Company | 2 | liquid; spray | Unapproved homeopathic products | December 17, 2025 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | spray | Unapproved homeopathic products | October 16, 2023 |
| Camber Pharmaceuticals, Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 28, 2025 |
| Civica, Inc. | 1 | injection, solution | Generic drugs (ANDA) | June 1, 2020 |
| Henry Schein, Inc. | 1 | injection, solution | Generic drugs (ANDA) | January 12, 2022 |
| Menper Distributors, Inc. | 1 | crystal | Over the counter monograph drugs | July 1, 2025 |
| Pharmadel LLC | 1 | crystal | Over the counter monograph drugs | August 1, 2024 |
| Remedyrepack Inc. | 1 | injection, solution | New drug applications (NDA) | June 28, 2025 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | February 15, 2021 |
| Square Pharmaceuticals Limited | 1 | injection, solution | Generic drugs (ANDA) | October 30, 2026 |
| Sun Pharmaceutical Industries, Inc. | 1 | injection, solution | Generic drugs (ANDA) | August 1, 2021 |
| Walmart Inc. | 1 | liquid | Unapproved homeopathic products | April 19, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 31 | 68.9% |
| Liquid | 4 | 8.9% |
| Spray | 3 | 6.7% |
| Crystal | 2 | 4.4% |
| Pellet | 2 | 4.4% |
| Aerosol, foam | 1 | 2.2% |
| Solution | 1 | 2.2% |
| Spray, metered | 1 | 2.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 48.9% |
| Unapproved homeopathic products | 12 | 26.7% |
| New drug applications (NDA) | 9 | 20% |
| Over the counter monograph drugs | 2 | 4.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Calculi Dissolution Agent | 45 |
| Osmotic Laxative | 45 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.